Zhu Qingwen, Zang Wen, Yuan Yongyi, Han Haixia, Zhang Xiqin, Jiang Xinxia, Ren Xiumin, Feng Caihong, Lu Hong
Department of Otolaryngology, Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Jan;26(1):22-6. doi: 10.13201/j.issn.1001-1781.2012.01.012.
To study the molecular pathogenesis of SLC26A4 mutations associated with inner ear malformations including large vestibular aqueduct syndrome (LVAS), Mondini dysplasia and inner ear malformations but not accompanied with LVAS.
DNA sample and clinical material were obtained from 14 sporadic LVAS probands, six Mondini dysplasia probands and seven inner ear malformations excluding IVAS probands. SLC26A4 gene mutation was analyzed by direct sequencing for its 20 coding exons. GJB2 gene and also mt12SrRNA were analyzed by direct sequencing.
In 14 cases of LVAS, two mutations were detected in 12 patients (85.7%, either homozygous or compound heterozygous mutations), and one mutation was found in two patients (14.3%). In six cases of Mondini dysplasia, two mutations were detected in all of patients (100%). No mutation could be found in the seven cases of other inner ear abnormalities not accompanied with LVAS. No pathogenic mutation was detected in all of these 27 probands in GJB2 gene and mt12SrRNA 1555/1494T.
We have shown that LVAS and Mondini dysplasia closely correlate with SLC26A4 gene. No mutation was detected in seven probands of inner ear malformations not accompanied with LVAS. We should study the molecular pathogenesis of this disease in depth.
研究与内耳畸形相关的SLC26A4突变的分子发病机制,这些内耳畸形包括大前庭导水管综合征(LVAS)、Mondini发育异常以及不伴有LVAS的内耳畸形。
从14例散发的LVAS先证者、6例Mondini发育异常先证者和7例不包括LVAS先证者的内耳畸形患者中获取DNA样本和临床资料。通过直接测序分析SLC26A4基因的20个编码外显子的突变情况。通过直接测序分析GJB2基因以及线粒体12SrRNA。
在14例LVAS患者中,12例患者检测到两个突变(85.7%,纯合或复合杂合突变),2例患者检测到一个突变(14.3%)。在6例Mondini发育异常患者中,所有患者均检测到两个突变(100%)。在7例不伴有LVAS的其他内耳异常患者中未发现突变。在所有这27例先证者中,GJB2基因和线粒体12SrRNA 1555/1494T均未检测到致病突变。
我们已经表明LVAS和Mondini发育异常与SLC26A4基因密切相关。在7例不伴有LVAS的内耳畸形先证者中未检测到突变。我们应该深入研究这种疾病的分子发病机制。